Safety data on GLP-1 use in pregnant women with diabetes is still thin, so an expert panel put together consensus guidance on the key questions.
Recap by typeshit. Full story at Medscape.
Dr. Nadolsky, an obesity medicine doctor, gives his take on a recent GLP-1 warning in a short clip. Tap through to see which warning he means.
2:12
A short explainer on the experimental injection people call Reta, covering why it went viral and what is known so far about its safety.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
32:25
The channel walks through FDA inspection findings of mold at suppliers and what people taking GLP-1 medications should watch for.
A Medscape opinion roundup on food cravings, the long-term staying power of bariatric surgery, and how tirzepatide is starting to compete with it.
28:35
An animated look at how many people are taking retatrutide before any approval, and what that means for the gray market.
Loading…